Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find clinical antiviral treatments. A promising drug target is the viral main protease M pro , which plays a key role in viral replication and transcription. Dai et al...
Saved in:
Published in | Science (American Association for the Advancement of Science) Vol. 368; no. 6497; pp. 1331 - 1335 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The American Association for the Advancement of Science
19.06.2020
American Association for the Advancement of Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!